OCTOBER
MDedge
FDA issues proposed order for over-the-counter sunscreens
Practice Update
Topical 5% 5-Fluorouracil Versus Procedural Modalities for Squamous Cell Carcinoma In Situ and Superficial Basal Cell Carcinoma
More Severe Psoriasis Linked to an Increased Risk of PsA
Dermatology Times
Recent report Demonstrates that Rejuvenating Laser Leads to Acne Agminate-Like Reaction
FDA approves topical ruxolitinib for atopic dermatitis, first JAK inhibitor for this indication in the U.S.
Healio Dermatology
Experts propose novel classification for COVID-19 vaccination skin reactions
LiVDerm, 1801 N Military Trl Ste 200, Boca Raton, FL 33431-1810, United States, 561-893-8625
Unsubscribe Manage preferences
